Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/131942| Title: | Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines |
| Authors: | Pace, David Pollard, Andrew J. |
| Keywords: | Neisseria meningitidis -- Epidemiology Meningococcal infections -- Prevention Meningococcal vaccines Vaccines, conjugate Pediatrics -- Immunological aspects |
| Issue Date: | 2007 |
| Publisher: | BMJ Group |
| Citation: | Pace, D., & Pollard, A. J. (2007). Meningococcal A, C, Y and W-135 polysaccharide-protein conjugate vaccines. Archives of Disease in Childhood, 92(10), 909-915. |
| Abstract: | Serogroup C meningococcal conjugate vaccines, first launched in the UK in 1999, have been used successfully in Australia, Canada and several other European countries. Combination conjugate vaccines, containing more than one meningococcal polysaccharide, have been developed to broaden protection against the disease. A tetravalent meningococcal A, C, Y and W-135 conjugate vaccine was licensed for use in 11–55 year old adolescents and adults in the US in January 2005, and subsequently also in 2–11 year old children in Canada in May 2006. This article discusses the different glycoconjugate meningococcal vaccines which have been developed and the potential for their use to control disease caused by serogroups A, C, Y and W-135 of Neisseria meningitidis. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/131942 |
| Appears in Collections: | Scholarly Works - FacM&SPae |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Meningococcal A C Y and W 135 polysaccharide protein conjugate vaccines 2007.pdf Restricted Access | 200.16 kB | Adobe PDF | View/Open Request a copy |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.